News


  • Featured
  • All News

28 Feb 2024

Suboxone $385 Million Settlement Receives Final Court Approval, Faruqi & Faruqi, LLP, Co-Lead Counsel

On February 27, 2024, Judge Mitchell S. Goldberg of the United States District Court for the Eastern District of Pennsylvania granted final approval to a $385 million settlement in In re Suboxone Antitrust Litigation, 13-md-02445 (E.D. Pa.). The settlement ...

Read more

22 Dec 2023

Faruqi & Faruqi, LLP Announces Lisa Omoto Promoted to Partner

Faruqi & Faruqi, LLP, is thrilled to announce that Lisa Omoto is promoted to Partner. Lisa focuses her practice on consumer protection litigation. ...

Features: Lisa Omoto

Read more

17 Nov 2023

Faruqi & Faruqi Appointed Sole Lead Counsel to Represent Lordstown Motors, Inc. Shareholders in Securities Class Action

On November 16, 2023, United States District Judge Benita Y. Pearson of the Northern District of Ohio appointed Faruqi & Faruqi, LLP, as sole lead counsel in Lim v. Hightower, et al., 23-cv-1454-BYP. The suit centers on false and misleading statements ...

Features: James M. Wilson, Jr.

Read more

14 Nov 2023

Faruqi & Faruqi Roars!

Faruqi & Faruqi was named a Legal Lion of the Week by Law360 on November 9, 2023 for winning the hotly contested motion for class certification in the Teva Pharmaceuticals securities class action. The Court in the Eastern District of Pennsylvania certified ...

Read more

10 Nov 2023

Faruqi & Faruqi, LLP Certified By the Women’s Business Enterprise National Council

[New York, NY]—November 11, 2023— Faruqi & Faruqi, LLP, a business specializing in legal services, is proud to announce national re-certification as a Women's Business Enterprise by the Women President's Educational Organization - NY, a regional certifying ...

Features: Lubna M. Faruqi

Read more

06 Nov 2023

FARUQI & FARUQI SCORES BIG WIN IN OBTAINING CLASS CERTIFICATION IN SECURITIES ACTION AGAINST TEVA PHARMACEUTICALS INDUSTRIES, LTD.

On November 3, 2023, Judge Karen S. Marston of the District Court for the Eastern District of Pennsylvania granted class certification in a securities action against Teva Pharmaceuticals Industries Limited ("Teva") and certain of its officers and directors, ...

Read more

01 Nov 2023

Suboxone Settlement

On October 30, 2023, the Court overseeing the Suboxone Direct Purchaser Class litigation preliminarily approved a $385 million settlement, reached days before trial was scheduled to begin. Faruqi and Faruqi are co-lead counsel for the Class, in this antitrust ...

Read more

01 Nov 2023

Judge Hellerstein in Novartis $126.85 Anti-Trust Class Action Settlement Approves Distribution of Funds. Faruqi & Faruqi, LLP, serves as Class Counsel.

On October 31, 2023, the Court overseeing the Exforge litigation granted direct purchaser plaintiffs' motion for distribution of the net settlement funds. The Court previously issued an order granting final approval to the $126.85 million settlement between ...

Read more

30 Oct 2023

Faruqi & Faruqi Scores Appellate Win for Consumers in Misleading “Reef Friendly” Sunscreen Case

On October 30, 2023, the Second Circuit Court of Appeals reversed a decision issued by the trial court in Richardson v. Edgewell Personal Care, Case No. 7:21-cv-08275, holding that the "Reef Friendly*" claim on the front-label of Hawaiian Tropic sunscreen ...

Features: Timothy J. Peter, Lisa Omoto, Kyle J. Conway

Read more

23 Oct 2023

Faruqi & Faruqi Achieves $385 Million Resolution for Direct Purchasers of Suboxone

New York— Faruqi & Faruqi, LLP announces that as co-lead counsel in the Suboxone Antitrust Litigation, it has achieved a $385 million settlement for a class composed of direct purchasers of Suboxone. The 10-year litigation in the Eastern District of ...

Features: Joseph T. Lukens, Peter Kohn

Read more

20 Sep 2023

Faruqi & Faruqi's Own Taylor J. Crabill Cited in Law360 Employment Authority

Faruqi & Faruqi attorney Taylor J Crabil was recently cited in a law360 article titled "5 Things To Know About Retaliation In Employment Law," by Jon Steingart. "The anti-retaliation provisions in employment laws are actually critical to furthering the ...

Features: Taylor J. Crabill

Read more

29 Aug 2023

Faruqi & Faruqi Appointed Sole Lead Counsel to Represent Shareholders in the Luminar Technologies, Inc. Securities Class Action

On August 29, 2023, United States District Judge Paul G. Byron of the Middle District of Florida appointed Faruqi & Faruqi, LLP, as sole lead counsel in Johnson v. Luminar Technologies, Inc., et al., 23-cv-982-PGB-LHP. The suit centers on false and misleading ...

Features: Robert W. Killorin, James M. Wilson, Jr.

Read more

29 Aug 2023

Faruqi & Faruqi, LLP, As Co-Lead Counsel, Secures Revival Of Synergy Pharmaceuticals Investors’ Suit At Second Circuit

On Monday, August 28, 2023, the Second Circuit Court of Appeals revived certain securities fraud claims previously dismissed in In re Synergy Pharmaceuticals, Inc. Sec. Litig., No. 18-cv-873, 2021 WL 4480625 (E.D.N.Y. Sept. 30, 2021). In a Summary Order, ...

Features: Katherine M. Lenahan

Read more

14 Aug 2023

Faruqi & Faruqi's Own Thomas Papain Cited in Forbes

Faruqi & Faruqi attorney Thomas Papain was recently cited in a Forbes article titled "How The SEC's Charge That Cryptos Are Securities Could Face An Uphill Battle," by Maria Gracia Santillana Linares. "The common enterprise requirement could be easily ...

Read more

11 Aug 2023

California Judge Agrees with Faruqi & Faruqi in Putative Class Action Against Defendant Johnson & Johnson that Aveeno Baby Products May Be Misleading

On August 9, 2023, United States District Judge Jesus Bernal ruled on Johnson & Johnson Consumer Inc.'s motion to dismiss in Schippell v. Johnson & Johnson Consumer Inc., Case No. 5:23-CV-00410-JGB-SHK (C.D. Cal.). Judge Bernal stated that all causes ...

Read more

10 Aug 2023

Faruqi & Faruqi Appointed Sole Lead Counsel to Represent Shareholders in the Ampio Pharmaceuticals Securities Class Action

On August 9, 2023, United States District Judge William J. Martinez of the District of Colorado appointed Faruqi & Faruqi, LLP, as lead counsel in Christopher Kain v. Ampio Pharmaceuticals, Inc., et. al., 22-cv-2105-WJM-MEH. The suit centers on false ...

Features: Robert W. Killorin, James M. Wilson, Jr.

Read more

24 Jul 2023

Faruqi & Faruqi Defeats Motion to Dismiss in Folgers Coffee Litigation

On July 24, 2023, Judge Beth Phillips of the Western District of Missouri denied J.M. Smucker's motion to dismiss a consolidated multidistrict litigation complaint in the matter In Re: Folgers Coffee Marketing Litigation, No. 4:21-md-02984-BP. Plaintiffs, ...

Read more

21 Jul 2023

Faruqi & Faruqi, LLP, Appointed Lead Counsel in Argo Blockchain plc Securities Litigation

On July 19, 2023, United States Magistrate Judge Sanket J. Bulsara of the Eastern District of New York appointed Faruqi & Faruqi, LLP, as lead counsel in Murphy v. Argo Blockchain plc et al, 1:23-cv-00572-NRM-SJB (E.D.N.Y.). The suit centers on false ...

Features: Robert W. Killorin, James M. Wilson, Jr.

Read more

16 Jun 2023

Faruqi & Faruqi, LLP Sponsors Hellenic Lawyers Association's Annual Judiciary Night

This year, Faruqi & Faruqi, LLP was a proud sponsor of the Hellenic Lawyers Association's (HLA's) annual Judiciary Night, held at Kyma Hudson Yards on June 13th. The HLA is an organization dedicated to connecting lawyers and law students of Hellenic descent, ...

Read more

16 Jun 2023

Faruqi & Faruqi, LLP Sponsors The Uniformed Firefighters Association’s Scholarship Fund Golf Outing

This year, Faruqi & Faruqi, LLP, was a proud sponsor of the Uniformed Firefighters Association's (UFA's) Scholarship Fund Golf Outing, held at the Garden City Country Club on June 12th. The UFA is a non-profit that represents the interests of New York ...

Read more

Finding us

Our Offices


Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331

California

1901 Avenue of the Stars Suite 1060
Los Angeles, California 90067
(424) 256-2884
(424) 256-2885

Georgia

3565 Piedmont Road NE Building Four, Suite 380
Atlanta, Georgia 30305
(404) 847-0617
(404) 506-9534

Pennsylvania

1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania